Affinity Chromatography Market

The Affinity Chromatography is a type of liquid chromatography that uses a biologically related agent as a stationary phase to purify or analyze specific sample components. Separation method is based on a specific binding interaction between an immobilized ligand and its binding partner.  It is a novel medical procedure used for the treatment of cardiac arrhythmias and liver, prostate, kidney, lung, and other forms of cancer.

Affinity chromatography is broadly segmented into systems and consumables which include columns, reagents and media. Consumables segment covers bio-specific ligand based consumables and pseudo bio-specific ligand based consumables. Biospecific ligand based consumables include protein A affinity, protein G affinity, protein L affinity, and lectin affinity; whereas pseudo bio-specific ligand based consumables include Immobilized metal affinity chromatography (IMAC), and dye ligand-based affinity. High demand for protein A and immobilized metal affinity chromatography by pharmaceutical companies in drug development, high research funding and budgets for biopharma research are some of the factors driving the growth of this industry. Additionally, the rising adoption of affinity chromatography in the development of monoclonal antibodies are also expected to provide a wide range of opportunities for players in the market. However, high cost of systems and consumables and dearth of skilled professionals are the factors inhibiting the growth of the market.